BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29131126)

  • 61. Histone H3 wild-type DIPG/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation.
    Castel D; Kergrohen T; Tauziède-Espariat A; Mackay A; Ghermaoui S; Lechapt E; Pfister SM; Kramm CM; Boddaert N; Blauwblomme T; Puget S; Beccaria K; Jones C; Jones DTW; Varlet P; Grill J; Debily MA
    Acta Neuropathol; 2020 Jun; 139(6):1109-1113. PubMed ID: 32193787
    [No Abstract]   [Full Text] [Related]  

  • 62. Diffuse midline glioma with H3 K27M mutation of the spinal cord: A series of 33 cases.
    Yao J; Wang L; Ge H; Yin H; Piao Y
    Neuropathology; 2021 Jun; 41(3):183-190. PubMed ID: 33599007
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prediction of H3 K27M-mutant in midline gliomas by magnetic resonance imaging: a systematic review and meta-analysis.
    Hua T; Zhuo Z; Duan Y; Li X; Gu H; Haller S; Zhang P; Liu X; Zhang L; Liu Y
    Neuroradiology; 2022 Jul; 64(7):1311-1319. PubMed ID: 35416485
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Spinal intramedullary H3K27M mutant glioma with vertebral metastasis: a case report.
    Handis C; Tanrıkulu B; Danyeli AE; Özek MM
    Childs Nerv Syst; 2021 Dec; 37(12):3933-3937. PubMed ID: 33742289
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Diffuse midline glioma H3K27M mutation in adult: A case report.
    Bhattarai AM; Mainali G; Jha P; Karki P; Adhikari A; Pandit A; Bhattarai AM
    Ann Med Surg (Lond); 2022 Apr; 76():103567. PubMed ID: 35495373
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Thoracic low grade glial neoplasm with concurrent H3 K27M and PTPN11 mutations.
    Argenziano MG; Furnari JL; Miller ML; Sun Y; Banu MA; Neira JA; Snuderl M; Bruce JN; Welch M; McCormick P; Canoll P
    Acta Neuropathol Commun; 2022 Apr; 10(1):64. PubMed ID: 35484611
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A case report of adult cerebellar high-grade glioma with H3.1 K27M mutation: a rare example of an H3 K27M mutant cerebellar tumor.
    Funata N; Nobusawa S; Nakata S; Yamazaki T; Takabagake K; Koike T; Maegawa T; Yamada R; Shinoura N; Mine Y
    Brain Tumor Pathol; 2018 Jan; 35(1):29-35. PubMed ID: 29264735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diffuse midline glioma of the cervical spinal cord with H3 K27M genotype phenotypically mimicking anaplastic ganglioglioma: a case report and review of the literature.
    Kraus TFJ; Machegger L; Pöppe J; Zellinger B; Dovjak E; Schlicker HU; Schwartz C; Ladisich B; Spendel M; Kral M; Reinhardt A; Winkler PA; Sotlar K
    Brain Tumor Pathol; 2020 Jul; 37(3):89-94. PubMed ID: 32451719
    [TBL] [Abstract][Full Text] [Related]  

  • 69. ACTION: a randomized phase 3 study of ONC201 (dordaviprone) in patients with newly diagnosed H3 K27M-mutant diffuse glioma.
    Arrillaga-Romany I; Lassman A; McGovern SL; Mueller S; Nabors B; van den Bent M; Vogelbaum MA; Allen JE; Melemed AS; Tarapore RS; Wen PY; Cloughesy T
    Neuro Oncol; 2024 May; 26(Supplement_2):S173-S181. PubMed ID: 38445964
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults.
    Feng J; Hao S; Pan C; Wang Y; Wu Z; Zhang J; Yan H; Zhang L; Wan H
    Hum Pathol; 2015 Nov; 46(11):1626-32. PubMed ID: 26297251
    [TBL] [Abstract][Full Text] [Related]  

  • 71. An H3F3A K27M-mutation in a sonic hedgehog medulloblastoma.
    Dottermusch M; Uksul N; Knappe UJ; Erdlenbruch B; Wefers AK
    Brain Pathol; 2022 May; 32(3):e13024. PubMed ID: 34747078
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Spinal Cord Diffuse Midline Gliomas With H3 K27m-Mutant: Clinicopathological Features and Prognosis.
    Wang YZ; Zhang YW; Liu WH; Chai RC; Cao R; Wang B; An SY; Jiang WJ; Xu YL; Yang J; Jia WQ
    Neurosurgery; 2021 Jul; 89(2):300-307. PubMed ID: 34015818
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Multiparametric MRI-Based Radiomics Model for Predicting H3 K27M Mutant Status in Diffuse Midline Glioma: A Comparative Study Across Different Sequences and Machine Learning Techniques.
    Guo W; She D; Xing Z; Lin X; Wang F; Song Y; Cao D
    Front Oncol; 2022; 12():796583. PubMed ID: 35311083
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
    Pachocki CJ; Hol EM
    J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Supracerebellar infratentorial approach with paramedian expansion for posterior third ventricular and pineal region lesions.
    Aboul-Enein H; El-Aziz Sabry AA; Hafez Farhoud A
    Clin Neurol Neurosurg; 2015 Dec; 139():100-9. PubMed ID: 26426425
    [TBL] [Abstract][Full Text] [Related]  

  • 76. H3 K27-altered diffuse midline glioma in adults arising from atypical regions: Two case reports and literature review.
    Sugii N; Ninomiya Y; Akimoto Y; Tsurubuchi T; Ishikawa E
    Radiol Case Rep; 2024 Jan; 19(1):200-206. PubMed ID: 38028289
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Imaging characteristics of adult H3 K27M-mutant gliomas.
    Qiu T; Chanchotisatien A; Qin Z; Wu J; Du Z; Zhang X; Gong F; Yao Z; Chu S
    J Neurosurg; 2019 Nov; 133(6):1662-1670. PubMed ID: 31731269
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Diffuse midline glioma with H3-K27M mutation: A rare case with GFAP-positive anucleate whorled patterns.
    Wang YH; Gu J; Yu JH; Fu L; Li QC; Qiu XS; Wang EH
    Medicine (Baltimore); 2022 Jun; 101(24):e29448. PubMed ID: 35713454
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cerebellar high-grade glioma with H3 K27M mutation: illustrative case.
    Takahashi M; Tomita Y; Yamada SM; Yamazaki K; Yokoo H; Aso T; Kawamoto M
    J Neurosurg Case Lessons; 2021 Feb; 1(6):CASE20112. PubMed ID: 36045933
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The landscape of tumor cell states and spatial organization in H3-K27M mutant diffuse midline glioma across age and location.
    Liu I; Jiang L; Samuelsson ER; Marco Salas S; Beck A; Hack OA; Jeong D; Shaw ML; Englinger B; LaBelle J; Mire HM; Madlener S; Mayr L; Quezada MA; Trissal M; Panditharatna E; Ernst KJ; Vogelzang J; Gatesman TA; Halbert ME; Palova H; Pokorna P; Sterba J; Slaby O; Geyeregger R; Diaz A; Findlay IJ; Dun MD; Resnick A; Suvà ML; Jones DTW; Agnihotri S; Svedlund J; Koschmann C; Haberler C; Czech T; Slavc I; Cotter JA; Ligon KL; Alexandrescu S; Yung WKA; Arrillaga-Romany I; Gojo J; Monje M; Nilsson M; Filbin MG
    Nat Genet; 2022 Dec; 54(12):1881-1894. PubMed ID: 36471067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.